Basis of Presentation and Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2025

Accounting Policies [Abstract]

Schedule of Computation of Basic and Diluted Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share attributable to common shareholders (in thousands, except share and per share amounts). As the exercise price of the Company’s pre-funded warrants is $0.001 per share, it was determined to be non-substantive for accounting purposes and the pre-funded warrants were included in the denominator of both basic and diluted loss per share:

	Three Months Ended June 30,						Six Months Ended June 30,
	2025			2024			2025			2024
Numerator:
Net loss attributable to common shareholders, basic	$	(42,744	)	$	(5,854	)	$	(66,092	)	$	(60,254	)
Change in fair value of the 2022 USD Financing Warrants		—			(13,445	)		(4,771	)		—
Net loss attributable to common shareholders, diluted	$	(42,744	)	$	(19,299	)	$	(70,863	)	$	(60,254	)
Denominator:
Weighted-average pre-funded warrants used in computing net loss per share attributable to common shareholders, basic		9,753,775			—			9,753,775			—
Weighted-average shares used in computing net loss per share attributable to common shareholders, basic		75,593,902			71,912,323			75,454,764			59,886,540
Total weighted-average shares used in computing net loss per share attributable to common shareholders, basic		85,347,677			71,912,323			85,208,539			59,886,540
Incremental shares from 2022 USD Financing Warrants		—			3,391,778			1,890,467			—
Total weighted-average shares used in computing net loss per share attributable to common shareholders, diluted		85,347,677			75,304,101			87,099,006			59,886,540
Net loss per share:
Basic	$	(0.50	)	$	(0.08	)	$	(0.78	)	$	(1.01	)
Diluted	$	(0.50	)	$	(0.26	)	$	(0.81	)	$	(1.01	)

Schedule of Potentially Dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share due to Anti-dilutive Effect

The following potentially dilutive securities have been excluded from the calculation of diluted net loss per share due to their anti-dilutive effect:

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
2022 USD Financing Warrants		4,949,954		—		—		5,989,300
Stock options		5,148,374		3,532,174		5,148,374		3,532,174
RSUs		5,960,422		1,740,809		5,960,422		1,740,809
Conversion Shares		1,010,059		997,506		1,010,059		997,506
Estimated ESPP awards		27,333		—		27,333		—
Total		17,096,142		6,270,489		12,146,188		12,259,789